Position
Squarepoint Ops LLC in Coya Therapeutics, Inc.
Back to the book · All holders of COYA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$75.3K$5.80 → $3.94
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 65.2K | $377.9K | — | — | — | 0.0% |
| Q1 2026 | 40.5K | $159.4K | $3.94 | −$75.3K | −$143.2K | 0.0% |